[Optical hallucinosis during benzodiazepine withdrawal in low-dose dependence].
Wolter-Henseler
D K
DK
Rheinische Landesklinik, Abteilung Gerontopsychiatrie, Langenfeld.
D000368:Aged; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D006212:Hallucinations / Q000139:chemically induced* / Q000188:drug therapy; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D010076:Oxazepam / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000209:etiology*; D014786:Vision Disorders / Q000139:chemically induced* / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D010076:Oxazepam; D006220:Haloperidol
Optische Halluzinose im Rahmen eines Benzodiazepinentzugs bei Low-Dose-Abhängigkeit.